Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus

Left ventricular hypertrophy (LVH) is one of the cardio-vascular continuum components, determining the prognosis of patient with essential hypertension (EH). Pathogenesis of LVH has a multifactor character. Important role in development of cardiomyocites hypertrophy, Intracardiac fibrosis, left vent...

Full description

Bibliographic Details
Main Authors:	A V Barsukov, D V Glukhovskoy, M S Talantseva, Z V Bagaeva, E V Pronina, M P Zobnina, T S Sveklina, A E Korovin
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2013-03-01
Series:	Системные гипертензии
Subjects:	essential hypertension left ventricular hypertrophy renin-angiotensin-aldosteron system telmisartan
Online Access:	https://syst-hypertension.ru/2075-082X/article/view/28961

Similar Items

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
by: N.D. Filipets, et al.
Published: (2019-02-01)

Investigations of Renin-Angiotensin Aldosterone System (RAAS) genes in hypertrophy in hypertrophic cardiomyopathy (HCM) founder families
by: Cloete, Ruben Earl Ashley
Published: (2012)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension
by: S.R.S. Freitas, et al.
Published: (2007-03-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
by: Zohreh Rahimi, et al.
Published: (2014-01-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
by: M L Maksimov, et al.
Published: (2017-03-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
by: Maksimov M.L., et al.
Published: (2017-02-01)

CLINICAL ASSOCIATIONS BETWEEN CORONAVIRUS INFECTION (COVID-19) AND ARTERIAL HYPERTENSION: PATHOGENETIC MECHANISMS AND DISCUSSION ON THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
by: Yakubava L. V., et al.
Published: (2020-11-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

MODULATION OF THE CARDIAC SODIUM/BICARBONATE COTRANSPORTER BY THE RENIN ANGIOTENSIN ALDOSTERONE SYSTEM: PATHOPHYSIOLOGICAL CONSEQUENCES.
by: Verónica Celeste De Giusti, et al.
Published: (2014-01-01)

The renin-angiotensin-aldosterone system (RAAS) – physiology and molecular mechanisms of functioning
by: Monika Chaszczewska-Markowska, et al.
Published: (2016-09-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
by: Natalia Muñoz-Durango, et al.
Published: (2016-06-01)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
by: M. Ekholm, et al.
Published: (2021-06-01)

Renin-angiotensin-aldosterone system in bodybuilders using supraphysiological doses of anabolic-androgenic steroids
by: K Chrostowski, et al.
Published: (2011-03-01)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
by: Soo Ji Jeon, et al.
Published: (2020-11-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
by: Agnieszka Dettlaff-Pokora, et al.
Published: (2021-04-01)

Resveratrol Suppresses Cardiac Renin Angiotensin System in the Late Phase of Left Ventricular Hypertrophy
by: Tahmineh Hashemizadeh, et al.
Published: (2019-04-01)

Bidirectional relationship between covid-19 and diabetes: Role of renin–angiotensin–aldosterone system and drugs modulating it
by: Razia Khanam
Published: (2021-01-01)

Renin-angiotensin system blockers and COVID-19
by: Emmanuelle Vidal-Petiot, et al.
Published: (2021-06-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

The role of tissue renin angiotensin aldosterone system in the development of endothelial dysfunction and arterial stiffness
by: Annayya R Aroor, et al.
Published: (2013-10-01)

Molecular Mechanisms Underlying Renin-Angiotensin-Aldosterone System Mediated Regulation of BK Channels
by: Zhen-Ye Zhang, et al.
Published: (2017-09-01)

The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension
by: Yang Liu, et al.
Published: (2020-06-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Cannot write session to /tmp/vufind_sessions/sess_kq22bab4l0l7cbevflfo5m7l4l